167 results on '"Blanco, Ester"'
Search Results
2. Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies
3. Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer
4. Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses
5. Assessment of myeloid-derived suppressor cell differentiation ex vivo
6. Diagnosis of celiac disease in clinical practice: Present and future
7. Diagnóstico de enfermedad celiaca en la práctica clínica: presente y futuro
8. Correction: Feasibility of a hybrid clinical trial for respiratory virus detection in toddlers during the influenza season(BMC Med Res Methodol, (2021), 21, 273, 10.1186/s12874-021-01474-9)
9. Feasibility of a hybrid clinical trial for respiratory virus detection in toddlers during the influenza season
10. Diagnosing the role of the state for local collective action: Types of action situations and policy instruments
11. Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
12. Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer
13. Chapter 6 - Assessment of myeloid-derived suppressor cell differentiation ex vivo
14. LAMC2 regulates key transcriptional and targetable effectors to support pancreatic cancer growth
15. Figure S3 from LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
16. Supplementary Data DS1 from LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
17. mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
18. PD-1/LAG-3 DYSFUNCTIONALITY SIGNATURES IN HUMAN CANCERS
19. Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors
20. LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
21. 41 - BENEFICIO DE LOS PROGRAMAS DE TRANSICIÓN EN ENFERMEDAD INFLAMATORIA INTESTINAL: ESTUDIO BUTTERFLY DE GETECCU Y SEGHNP
22. Cutting-Edge CAR Engineering: Beyond T Cells
23. Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy
24. Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination
25. Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions
26. How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells
27. How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells
28. Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer
29. Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor
30. Potent clinical predictive and systemic adjuvant therapeutic value of plasma fractalkine in PD-L1/PD-1 blockade immunotherapy for lung cancer
31. IMMUNE PROFILING UNCOVERS POTENT ADJUVANT CAPACITIES OF SARS-COV-2 INFECTION TO VACCINATION LEADING TO MEMORY T CELL RESPONSES WITH A TH17 SIGNATURE IN CANCER PATIENTS
32. CAR-T Cells for the Treatment of Lung Cancer
33. LAG-3 Role in Cardiovascular Diseases
34. Role of the next-generation immune checkpoint LAG-3 in response and resistance to cancer immunotherapy
35. PD-L1/PD-1 Blockade Immunotherapy: Mechanism of response and resistance
36. LAG-3 Role in Neurological Diseases
37. Unique protein expression profiles discriminate ex vivo differentiated monocytic MDSCs from TAMs.
38. LAG-3 Role in Inflammatory Diseases
39. Bioinformatic tools for proteomic data analysis
40. Can ecolabels survive in the long run?: The role of initial conditions
41. A dynamic approach to voluntary environmental contributions in tourism
42. Economic incentives for tourism firms to undertake voluntary environmental management
43. LAG-3 Role in Infection
44. A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets
45. Understanding LAG-3 Signaling
46. Feasibility of a hybrid clinical trial for respiratory virus detection in toddlers during the influenza season
47. A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets
48. Feasibility of a hybrid clinical trial for respiratory virus detection in toddlers during the influenza season (Preprint)
49. Hyperprogressive Disease: Main Features and Key Controversies
50. PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.